Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Re EGM

13 Aug 2010 16:24

RNS Number : 0819R
Ark Therapeutics Group PLC
13 August 2010
Β 

ο»Ώ

ARK THERAPEUTICS GROUP PLC (the "Company")

Β 

POSTPONEMENT OF EXTRAORDINARY GENERAL MEETING ("EGM")

Β 

In light of representations made to the Company by a number of shareholders, in part prompted by unavailability over the summer holiday season, the Board has taken the decision to reschedule the EGM from 11.00 a.m. on 19 August 2010 to 12 noon on 6 September 2010. The location of the EGM will not change.

Β 

This will, in addition, allow the Board to convene and consider in detail the next steps in the implementation of its strategy, informed by its discussions with Iain Ross who has spent the recent weeks working alongside management undertaking a wholesale review of the Group's business and operations. The Board wishes to inform shareholders of the outcome of those deliberations in advance of the EGM and will, therefore, provide a further update as part of its half-yearly report, which is scheduled to be released on 25 August.

Β 

In accordance with the Articles, the Board shall provide details of the postponed EGM in twoΒ UKΒ national newspapers.

Β 

EGM Deadline and Voting Formalities

Β 

The current forms of proxy remain valid. The new deadline for the writtenΒ forms of proxy must be submitted byΒ 12 noon on 2 SeptemberΒ 2010. Forms of proxy that have beenΒ validly submitted byΒ shareholders to date shall remain valid for theΒ postponed EGM.

Β 

Save as expressly stated in this document, the contents of the original notice of extraordinary general meeting, including without limitation the business to be conducted at the meeting and the Board's recommendation, shall be unchanged. Words and expressions defined in the original notice for the EGM, shall, unless the context otherwise requires, have the same meaning when read in this document. All otherΒ terms andΒ provisions of the Company's original notice for the EGMΒ along with the forms of proxyΒ (all dated 28 July 2010)Β shall apply. For further details and copies of the relevant documents, please go toΒ www.arktherapeutics.com.

Β 

A letter has been sent to the Company's shareholders setting out the information above, two copies of which have been sent to the UK Listing Authority Document Viewing Facility and will be available for viewing shortly.

Β 

Β 

Β 

For further information:

Β 

Ark Therapeutics Group plc

Tel: + 44 (0)20 7388 7722

Martyn Williams, CEO

Β 

Andrew Christie, Chairman

Β 

Β 

Β 

Financial Dynamics

Tel: +44 (0)20 7831 3113

Ben Atwell

Β 

Susan Quigley

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBUGDIXDBBGGX
Date   Source Headline
8th Jun 20078:00 amRNSBlocklisting Interim Review
8th Jun 20078:00 amRNSBlocklisting Interim Review
7th Jun 20077:00 amRNSKerraped Launch
31st May 200710:13 amRNSVoting Rights and Capital
31st May 20077:02 amRNSResearch Update
22nd May 20077:01 amRNSTrinam Update
2nd May 20077:01 amRNSTrinam(R) RAC Application
30th Apr 20074:10 pmRNSVoting Rights and Capital
27th Apr 20077:01 amRNSRegulatory Update
26th Apr 20075:29 pmRNSResult of AGM
24th Apr 20077:01 amRNSResearch Update
2nd Apr 20071:42 pmRNSVoting Rights and Capital
2nd Apr 200712:22 pmRNSAnnual Information Update
30th Mar 20071:57 pmRNSHolding(s) in Company
19th Mar 20072:20 pmRNSBlock Listing Application
15th Mar 20075:37 pmRNSHolding(s) in Company
12th Mar 20072:12 pmRNSHolding(s) in Company
7th Mar 20077:01 amRNSFinal Results
5th Mar 20075:33 pmRNSHolding(s) in Company
1st Mar 200710:40 amRNSVoting Rights and Capital
23rd Feb 20079:00 amRNSHolding(s) in Company
22nd Feb 20077:01 amRNSStroke Patent
16th Feb 20079:00 amRNSHolding(s) in Company
16th Feb 20077:00 amRNSResearch Update
6th Feb 20071:03 pmRNSHolding(s) in Company
5th Feb 20072:41 pmRNSOption Awards
1st Feb 20077:01 amRNSEuropean Grant Awarded
25th Jan 20075:19 pmRNSHolding(s) in Company
22nd Jan 200711:24 amRNSTotal Voting Rights
19th Jan 200712:28 pmRNSNotice of Results
15th Jan 200712:45 pmRNSRe: Award
11th Jan 20077:01 amRNSResearch Update
5th Jan 20077:53 amRNSResearch Update
20th Dec 20062:00 pmRNSHolding(s) in Company
20th Dec 200610:28 amRNSVoting and Rights Capital
18th Dec 20067:01 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSPlacing of Shares
4th Dec 200611:26 amRNSBlocklisting Interim Review
4th Dec 200611:21 amRNSBlocklisting Interim Review
27th Nov 20061:44 pmRNSHolding(s) in Company
13th Oct 20067:00 amRNSCerepro Patent Granted
10th Oct 20067:01 amRNSRe: Kerraboot
2nd Oct 20063:49 pmRNSHolding(s) in Company
27th Sep 20067:01 amRNSResearch Update
8th Sep 20064:11 pmRNSHolding(s) in Company
5th Sep 20067:03 amRNSResearch Update
1st Sep 20067:00 amRNSCerepro EMEA review
30th Aug 20067:01 amRNSInterim Results
23rd Aug 20067:01 amRNSResearch Update
4th Aug 200612:50 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.